EpiEndo Pharmaceuticals
EpiEndo Pharmaceuticals is a pharmaceutical company focused on novel solutions for chronic airway diseases.
EpiEndo Pharmaceuticals has raised €25M across 3 funding rounds from 4 investors, most recently a Series A round in Aug 2021. Based in Reykjavík, Iceland; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€25M
€25,300,000
Funding rounds
3
Investors
4
distinct backers
Active since
2019-01
latest 2021-08
Funding by year
EUR raised per yearEpiEndo Pharmaceuticals — funding by year — interactive chart.
Data table
| EpiEndo Pharmaceuticals — funding by year | |
|---|---|
| 2018 | €800k |
| 2019 | €4.5M |
| 2021 | €20M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-18 | Series A | €20M | Iðunn Venture Fund,ABC Ventures,European Innovation Council (EIC),Flerie Invest | View deal → |
| 2019-10-01 | Grant | €4.5M | — | View deal → |
| 2019-01-01 | Other | €800k | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData